The role of biochemical diagnostics when determining the severity of disease in COVID-19 patients
1 June 2020

In this application note, Radiometer discusses the role of biochemical diagnostics when determining the severity of disease in COVID-19 patients. This application note highlights how there are elevated levels of fibrin-related markers, D-dimer, and Fibrinogen Degradation Products in COVID-19 related deaths and discusses how these can be used to determine the severity of the disease.